Structure Therapeutics, Inc. (GPCR)
41.53
+0.28
(+0.68%)
USD |
NASDAQ |
Jun 10, 16:00
41.49
-0.04
(-0.10%)
After-Hours: 20:00
Structure Therapeutics Market Cap : 2.952B for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 09, 2026 | 2.932B |
| June 08, 2026 | 2.684B |
| June 05, 2026 | 2.671B |
| June 04, 2026 | 2.776B |
| June 03, 2026 | 2.665B |
| June 02, 2026 | 2.643B |
| June 01, 2026 | 2.740B |
| May 29, 2026 | 2.796B |
| May 28, 2026 | 2.855B |
| May 27, 2026 | 2.810B |
| May 26, 2026 | 2.813B |
| May 22, 2026 | 2.785B |
| May 21, 2026 | 2.757B |
| May 20, 2026 | 2.621B |
| May 19, 2026 | 2.550B |
| May 18, 2026 | 2.567B |
| May 15, 2026 | 2.750B |
| May 14, 2026 | 2.832B |
| May 13, 2026 | 2.707B |
| May 12, 2026 | 2.689B |
| May 11, 2026 | 2.724B |
| May 08, 2026 | 2.779B |
| May 07, 2026 | 2.783B |
| May 06, 2026 | 2.903B |
| May 05, 2026 | 2.921B |
| Date | Value |
|---|---|
| May 04, 2026 | 3.059B |
| May 01, 2026 | 2.990B |
| April 30, 2026 | 2.936B |
| April 29, 2026 | 2.930B |
| April 28, 2026 | 3.086B |
| April 27, 2026 | 3.211B |
| April 24, 2026 | 3.223B |
| April 23, 2026 | 3.331B |
| April 22, 2026 | 3.294B |
| April 21, 2026 | 3.318B |
| April 20, 2026 | 3.416B |
| April 17, 2026 | 3.595B |
| April 16, 2026 | 3.790B |
| April 15, 2026 | 3.843B |
| April 14, 2026 | 3.770B |
| April 13, 2026 | 3.843B |
| April 10, 2026 | 3.862B |
| April 09, 2026 | 3.906B |
| April 08, 2026 | 3.762B |
| April 07, 2026 | 3.874B |
| April 06, 2026 | 3.667B |
| April 02, 2026 | 3.789B |
| April 01, 2026 | 3.554B |
| March 31, 2026 | 3.415B |
| March 30, 2026 | 3.113B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.072T |
| Novo Nordisk A/S | 144.16B |
| Viking Therapeutics, Inc. | 3.215B |
| Pfizer Inc. | 145.95B |
| Tarsus Pharmaceuticals, Inc. | 2.639B |
Market Cap Related Metrics
| PEG Ratio | -3.466 |
| Price to Book Value | 2.040 |
| Price | 41.53 |
| Earnings Yield | -6.48% |
| PEGY Ratio | -3.466 |